Open AccessGemcitabine in elderly patients with advanced pancreatic cancer
Author(s) -
Olivia Hentic,
Chantal Dreyer,
Vinciane Rebours,
Magaly Zappa,
Philippe Lévy,
Éric Raymond,
Philippe Ruszniewski,
Pascal Hammel
Publication year - 2011
Publication title -
world journal of gastroenterology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.427
H-Index - 155
eISSN - 2219-2840
pISSN - 1007-9327
DOI - 10.3748/wjg.v17.i30.3497
Subject(s) - gemcitabine , medicine , tolerability , neutropenia , chemotherapy , pancreatic cancer , performance status , cancer , oncology , retrospective cohort study , adenocarcinoma , gastroenterology , surgery , adverse effect
To assess feasibility, tolerability and efficacy of gemcitabine-based chemotherapy in patients ≥ 75 years old with advanced pancreatic cancer.